| Characteristic . | Persistent AF . | Paroxysmal AF . | P . |
|---|---|---|---|
| Baseline AF cycle length (at coronary sinus), ms | 170 ± 21 | 189 ± 13 | 0.03 |
| Patients with detected sources | 28/29 (97%) | 7/7 (100%) | |
| Patients reaching acute endpoint | 24/29 (82.8%) | 7/7 (100%) | |
| No. of concurrent AF sources | 2.4 ± 1.1 | 1.9 ± 0.7 | 0.23 |
| No. of rotors, %a (LA/RA) | 74.1% (29/14) | 61.5% (6/2) | |
| No. of focal impulses, %a (LA/RA) | 25.9% (15/0) | 38.5% (5/0) | |
| FIRM time to AF termination, primary source/min | 4.5 ± 7.3 | 3.9 ± 4.1 | 0.86 |
| Total FIRM time, all sources/min | 17.5 ± 10.5 | 7.7 ± 4.2 | 0.29 |
| ECG analyses | |||
| XY phase lock | 0.12 ± 0.06 | 0.11 ± 0.02 | 0.60 |
| XZ phase lock | 0.12 ± 0.04 | 0.11 ± 0.06 | 0.40 |
| YZ phase lock | 0.14 ± 0.06 | 0.12 ± 0.04 | 0.53 |
| X (ECG I) DF/Hz | 4.90 ± 1.04 | 4.85 ± 1.17 | 0.91 |
| X (ECG I) organization index | 0.39 ± 0.15 | 0.34 ± 0.06 | 0.35 |
| Y (ECG aVF) DF/Hz | 5.22 ± 0.88 | 5.42 ± 0.46 | 0.56 |
| Y (ECG aVF) organization index | 0.41 ± 0.21 | 0.33 ± 0.14 | 0.35 |
| Z (ECG V1) DF/Hz | 5.32 ± 1.16 | 5.20 ± 0.63 | 0.80 |
| Z (ECG V1) organization index | 0.42 ± 0.16 | 0.32 ± 0.18 | 0.17 |
| Characteristic . | Persistent AF . | Paroxysmal AF . | P . |
|---|---|---|---|
| Baseline AF cycle length (at coronary sinus), ms | 170 ± 21 | 189 ± 13 | 0.03 |
| Patients with detected sources | 28/29 (97%) | 7/7 (100%) | |
| Patients reaching acute endpoint | 24/29 (82.8%) | 7/7 (100%) | |
| No. of concurrent AF sources | 2.4 ± 1.1 | 1.9 ± 0.7 | 0.23 |
| No. of rotors, %a (LA/RA) | 74.1% (29/14) | 61.5% (6/2) | |
| No. of focal impulses, %a (LA/RA) | 25.9% (15/0) | 38.5% (5/0) | |
| FIRM time to AF termination, primary source/min | 4.5 ± 7.3 | 3.9 ± 4.1 | 0.86 |
| Total FIRM time, all sources/min | 17.5 ± 10.5 | 7.7 ± 4.2 | 0.29 |
| ECG analyses | |||
| XY phase lock | 0.12 ± 0.06 | 0.11 ± 0.02 | 0.60 |
| XZ phase lock | 0.12 ± 0.04 | 0.11 ± 0.06 | 0.40 |
| YZ phase lock | 0.14 ± 0.06 | 0.12 ± 0.04 | 0.53 |
| X (ECG I) DF/Hz | 4.90 ± 1.04 | 4.85 ± 1.17 | 0.91 |
| X (ECG I) organization index | 0.39 ± 0.15 | 0.34 ± 0.06 | 0.35 |
| Y (ECG aVF) DF/Hz | 5.22 ± 0.88 | 5.42 ± 0.46 | 0.56 |
| Y (ECG aVF) organization index | 0.41 ± 0.21 | 0.33 ± 0.14 | 0.35 |
| Z (ECG V1) DF/Hz | 5.32 ± 1.16 | 5.20 ± 0.63 | 0.80 |
| Z (ECG V1) organization index | 0.42 ± 0.16 | 0.32 ± 0.18 | 0.17 |
aLA, left atrium; RA, right atrium.
| Characteristic . | Persistent AF . | Paroxysmal AF . | P . |
|---|---|---|---|
| Baseline AF cycle length (at coronary sinus), ms | 170 ± 21 | 189 ± 13 | 0.03 |
| Patients with detected sources | 28/29 (97%) | 7/7 (100%) | |
| Patients reaching acute endpoint | 24/29 (82.8%) | 7/7 (100%) | |
| No. of concurrent AF sources | 2.4 ± 1.1 | 1.9 ± 0.7 | 0.23 |
| No. of rotors, %a (LA/RA) | 74.1% (29/14) | 61.5% (6/2) | |
| No. of focal impulses, %a (LA/RA) | 25.9% (15/0) | 38.5% (5/0) | |
| FIRM time to AF termination, primary source/min | 4.5 ± 7.3 | 3.9 ± 4.1 | 0.86 |
| Total FIRM time, all sources/min | 17.5 ± 10.5 | 7.7 ± 4.2 | 0.29 |
| ECG analyses | |||
| XY phase lock | 0.12 ± 0.06 | 0.11 ± 0.02 | 0.60 |
| XZ phase lock | 0.12 ± 0.04 | 0.11 ± 0.06 | 0.40 |
| YZ phase lock | 0.14 ± 0.06 | 0.12 ± 0.04 | 0.53 |
| X (ECG I) DF/Hz | 4.90 ± 1.04 | 4.85 ± 1.17 | 0.91 |
| X (ECG I) organization index | 0.39 ± 0.15 | 0.34 ± 0.06 | 0.35 |
| Y (ECG aVF) DF/Hz | 5.22 ± 0.88 | 5.42 ± 0.46 | 0.56 |
| Y (ECG aVF) organization index | 0.41 ± 0.21 | 0.33 ± 0.14 | 0.35 |
| Z (ECG V1) DF/Hz | 5.32 ± 1.16 | 5.20 ± 0.63 | 0.80 |
| Z (ECG V1) organization index | 0.42 ± 0.16 | 0.32 ± 0.18 | 0.17 |
| Characteristic . | Persistent AF . | Paroxysmal AF . | P . |
|---|---|---|---|
| Baseline AF cycle length (at coronary sinus), ms | 170 ± 21 | 189 ± 13 | 0.03 |
| Patients with detected sources | 28/29 (97%) | 7/7 (100%) | |
| Patients reaching acute endpoint | 24/29 (82.8%) | 7/7 (100%) | |
| No. of concurrent AF sources | 2.4 ± 1.1 | 1.9 ± 0.7 | 0.23 |
| No. of rotors, %a (LA/RA) | 74.1% (29/14) | 61.5% (6/2) | |
| No. of focal impulses, %a (LA/RA) | 25.9% (15/0) | 38.5% (5/0) | |
| FIRM time to AF termination, primary source/min | 4.5 ± 7.3 | 3.9 ± 4.1 | 0.86 |
| Total FIRM time, all sources/min | 17.5 ± 10.5 | 7.7 ± 4.2 | 0.29 |
| ECG analyses | |||
| XY phase lock | 0.12 ± 0.06 | 0.11 ± 0.02 | 0.60 |
| XZ phase lock | 0.12 ± 0.04 | 0.11 ± 0.06 | 0.40 |
| YZ phase lock | 0.14 ± 0.06 | 0.12 ± 0.04 | 0.53 |
| X (ECG I) DF/Hz | 4.90 ± 1.04 | 4.85 ± 1.17 | 0.91 |
| X (ECG I) organization index | 0.39 ± 0.15 | 0.34 ± 0.06 | 0.35 |
| Y (ECG aVF) DF/Hz | 5.22 ± 0.88 | 5.42 ± 0.46 | 0.56 |
| Y (ECG aVF) organization index | 0.41 ± 0.21 | 0.33 ± 0.14 | 0.35 |
| Z (ECG V1) DF/Hz | 5.32 ± 1.16 | 5.20 ± 0.63 | 0.80 |
| Z (ECG V1) organization index | 0.42 ± 0.16 | 0.32 ± 0.18 | 0.17 |
aLA, left atrium; RA, right atrium.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
